Top ten well-known foreign institutional investors’ heavily weighted A-share stocks unveiled—including Goldman Sachs, Morgan Stanley, JPMorgan Chase, UBS, and Barclays Bank!

Moreover, Morgan Stanley’s top five A-share holdings by circulating market value are: Huace Testing (RMB 367 million), Keli Sensing (RMB 160 million), Haier Biotech (RMB 136 million), Xusheng Group (RMB 136 million), and Wolong Electric Drive (RMB 130 million). Among these, Huace Testing was a major new position added by Morgan Stanley in Q3 last year; however, according to the latest data, Morgan Stanley reduced its stake in this stock over the past two quarters. UBS: Over RMB 2 billion invested in gold-related stocks—massive gains! As of end-2024, UBS appeared among the top ten circulating shareholders of 128 A-share listed companies, with a total holding value of approximately RMB 6.08 billion. Although the number of holdings declined from 192 (valued at RMB 3.967 billion) as of end-Q3 2024, the total market value of UBS’s holdings surged significantly. Specifically, as of April 29, the top five UBS-held stocks ranked by price appreciation were: *ST Ningke (+113.85%), Ketai Power Supply (+92.60%), Ampereon (+69.99%), Jielun Intelligent (+61.73%), and Hanyu Group (+93.74%). In terms of shareholding ratio, Tegene Life Sciences had the highest UBS stake relative to its circulating shares: as of end-2024, UBS held 7.772 million shares valued at RMB 110 million. Since end-2024, the stock has fallen 8.15%, resulting in an estimated unrealized loss of nearly RMB 9 million for UBS; UBS reduced its position by 500,000 shares in Q4. Regarding holding value, only six stocks held by UBS exceeded RMB 100 million in Q3, three of which were newly added positions. Notably, Zijin Mining—a gold-related stock—was aggressively accumulated by UBS in Q4 with a RMB 2.7 billion position. Since end-2024, the stock has risen 13.45%, generating an estimated unrealized gain of RMB 363 million for UBS. Barclays Bank: Overall portfolio is highly diversified! Numerous newly established positions! As of end-2024, Barclays Bank appeared among the top ten circulating shareholders of 115 A-share listed companies, with a total holding value of approximately RMB 1.327 billion. At end-Q3 2024, Barclays held stakes in 222 companies (valued at RMB 2.413 billion); overall, it reduced its positions, maintained a highly diversified portfolio, and held no single stock exceeding RMB 100 million in value—indicating active trading and numerous newly established positions. As of April 29, the top five Barclays-held stocks ranked by price appreciation were: Weichai Heavy Machinery (+84.10%), Juliu Rigging (+36.43%), Tianfu Culture & Tourism (+30.65%), Shengtong Energy (+29.90%), and Jusailong (+29.49%). In terms of shareholding ratio, among the top 20 stocks by UBS’s stake percentage, 13 were newly added in Q4, while five stocks saw increased positions. The stocks with increased positions (by number of shares) were: Lianhe Precision (+90,700 shares), Yitian Co., Ltd. (+78,100 shares), Zhidi Technology (+162,400 shares), Sentai Co., Ltd. (+39,500 shares), and Degute (+31,100 shares). Regarding holding value, 53 stocks held by Barclays had individual positions exceeding RMB 10 million. Among them, Weichai Heavy Machinery—a robotics-related stock—was newly accumulated by Barclays with over RMB 20 million in Q4. Since end-2024, the stock has risen 84.10%, generating an estimated unrealized gain of over RMB 15 million for Barclays.

What are Barclays Bank’s latest A-share holdings? Detailed list of Barclays Bank’s Q1 2026 equity positions.

Barclays Bank is a leading UK-based global multinational financial group with deep expertise in cross-border equity investment and a long-term strategic focus on high-quality A-share listed companies across multiple sectors. According to data from Private Equity Ranking Network’s prominent investor holdings, as of April 21, 2026, Barclays Bank held stakes in over twenty A-share listed companies in Q1 2026, covering diverse industry segments including acoustic components, industrial automation, pharmaceutical distribution, optical communications, precision non-ferrous metals, food & consumer goods, oil & gas equipment, livestock farming, and electrothermal materials. View Barclays Bank’s latest A-share holdings: Barclays Bank’s Q1 2026 Holdings Data shows that Barclays Bank’s holdings include Gongda Electronics, Keyuan Wisdom, Luyan Pharmaceutical, Ligong Optical Fiber, Ruixin Technology, Shenke Shares, Huifa Food, Deshi Shares, Xiaoming Shares, and Rainbow Group, among others. From the Q1 2026 holdings perspective, most of Barclays Bank’s positions were newly established this quarter; some existing positions received share increases, while only a few experienced minor reductions. Barclays Bank’s stake in any single company represented a relatively low percentage of that company’s total share capital, reflecting an overall strategy of diversified portfolio allocation. 1. Gongda Electronics Gongda Electronics specializes in R&D and manufacturing of miniature electro-acoustic components, focusing on acoustic modules and smart audio supporting products, continuously adapting to application scenarios in consumer electronics and smart terminals. During the Q1 2026 reporting period, Barclays Bank newly established a position in Gongda Electronics, with the corresponding holding value ranking among the highest across all its current holdings. 2. Keyuan Wisdom Keyuan Wisdom primarily provides industrial automation and energy information management systems and services, covering细分 scenarios such as intelligent manufacturing, power plant operations & maintenance, and smart industry—supporting digital transformation and upgrading of traditional industries. Barclays Bank newly established a position in Keyuan Wisdom this quarter, strategically investing in the long-term growth trajectory of industrial digitization. 3. Luyan Pharmaceutical Luyan Pharmaceutical operates across the full pharmaceutical distribution value chain, covering drug distribution, medical supply chain services, and pharmaceutical retail support—effectively bridging pharmaceutical production and end-user healthcare consumption markets. As a key target for Barclays Bank’s strategic allocation, the institution newly established a position in Luyan Pharmaceutical’s circulating shares this quarter. 4. Ligong Optical Fiber Ligong Optical Fiber focuses on R&D and real-world deployment of fiber-optic sensing technologies, serving applications in security monitoring, transportation sensing, and energy pipeline monitoring, continuously expanding its business scope within IoT sensing solutions. In Q1 2026, Barclays Bank modestly increased its position in Ligong Optical Fiber, reinforcing its allocation in the specialized optical-sensing segment. 5. Ruixin Technology Ruixin Technology specializes in precision non-ferrous metal tubing and lightweight alloy component processing, closely aligning with industrial chain demands in new-energy vehicles, high-end equipment, and power transmission. Barclays Bank increased its position in Ruixin Technology this quarter, continuing its strategic allocation to the high-end non-ferrous processing sector. 6. Shenke Shares Shenke Shares focuses on sliding bearing equipment manufacturing, serving heavy machinery integration and transmission component applications, meeting operational support requirements for industrial equipment. Barclays Bank substantially increased its position in Shenke Shares this period, while simultaneously reducing stakes in another batch of holdings—demonstrating flexible adjustments to its individual stock allocations. 7. Huifa Food Huifa Food concentrates on R&D and production of prepared dishes and frozen foods, serving diverse food scenarios including catering supply chains and household daily consumption, continuously expanding its footprint in food processing.

Barclays Initiates Coverage on Element Solutions Inc with Overweight Rating

Oct 13, 2026

Barclays has initiated coverage on Element Solutions Inc (ESI) with an Overweight rating and a $53 price target. The firm views the stock as undervalued despite a high P/E ratio compared to historical medians.

GuruFocus

2026-07-22

Element Solutions Inc. ESI Shares Purchased by Bank of New York Mellon Corp

2026-07-28

Element Solutions Inc Stock Market Trends and Trading Analysis

2026-07-28

Element Solutions Inc (ESI) Q2 2026 Earnings Call Highlights: Record Revenue and Raised Guidance

2026-08-01

Segall Bryant & Hamill LLC Has $62.11 Million Stake in Element Solutions Inc. (ESI)

2026-08-03

HSBC Holdings Significantly Reduces Stake in Element Solutions Inc.